2015-04-10 19:37:39 UTC

IBD Self-Management: The AGA Guide to Crohn’s Disease and Ulcerative Colitis (2nd Ed.)

Author Sunanda V. Kane, MD, MSPH, shares practical yet detailed information, including the latest IBD treatments, in a warm, compassionate tone that will motivate patients to successfully face life with Crohn’s disease or ulcerative colitis.

The second edition features a revised chapter on medications for IBD, offering the most up-to-date information on treatment currently available.

Dr. Kane’s book is a wonderful source of useful information and support to IBD patients and an outstanding contribution to the clinical literature for IBD physicians.”—Joseph B. Kirsner, MD, PhD

Right from the start, this is a terrific book. A lot of patients with IBD will read this book—and be happy they did!”—David Weinberg, MD, Minnesota Gastroenterology, Plymouth, MN

About the Author

Sunanda V. Kane, MD, MSPH
Sunanda V. Kan, MD, MSPH, is an internationally renowned authority on treatment of IBD who sees patients and conducts research at the Mayo Clinic in Rochester, MN. Dr. Kane lead education programs for IBD patients and their caregivers for groups like the Crohn's & Colitis Foundation of America (ccfa.org) and the Foundation for Clinical Research in Inflammatory Bowel Disease (myibd.org). She speaks around the the world to health-care professionals and encourages those with Crohn's disease or ulcerative colitis to understand their options and embrace their important role in managing their disease.

More on Crohn's Disease

Leading patient, professional organizations announce funding to improve communications, address IBD shared decision-making

April 17, 2018

Funding recipients will address ways to improve shared decision-making and effective health communications.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

The Development and Approval of Inflectra, a Biosimilar to Remicade: Case Presentation

April 3, 2018

In this on-demand webinar, Sue Lim, MD of the FDA provides a general review of the requirements for a biosimilar 351(k) application and discusses the approval process for Inflectra.